331 related articles for article (PubMed ID: 15544326)
1. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy.
Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP
Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326
[TBL] [Abstract][Full Text] [Related]
2. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
[TBL] [Abstract][Full Text] [Related]
3. STD and TRNOESY NMR studies for the epitope mapping of the phosphorylation motif of the oncogenic protein beta-catenin recognized by a selective monoclonal antibody.
Megy S; Bertho G; Gharbi-Benarous J; Baleux F; Benarous R; Girault JP
FEBS Lett; 2006 Oct; 580(22):5411-22. PubMed ID: 16996060
[TBL] [Abstract][Full Text] [Related]
4. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP.
Evrard-Todeschi N; Gharbi-Benarous J; Bertho G; Coadou G; Megy S; Benarous R; Girault JP
Peptides; 2006 Jan; 27(1):194-210. PubMed ID: 16165251
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 encoded virus protein U (Vpu) solution structure of the 41-62 hydrophilic region containing the phosphorylated sites Ser52 and Ser56.
Coadou G; Evrard-Todeschi N; Gharbi-Benarous J; Benarous R; Girault JP
Int J Biol Macromol; 2002 Mar; 30(1):23-40. PubMed ID: 11893391
[TBL] [Abstract][Full Text] [Related]
6. Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-catenin.
Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Tanchou V; Benarous R; Girault JP
Biochemistry; 2008 Jan; 47(1):14-29. PubMed ID: 18052253
[TBL] [Abstract][Full Text] [Related]
7. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
Schubert U; Henklein P; Boldyreff B; Wingender E; Strebel K; Porstmann T
J Mol Biol; 1994 Feb; 236(1):16-25. PubMed ID: 8107101
[TBL] [Abstract][Full Text] [Related]
8. Structural studies on 24P-IkappaBalpha peptide derived from a human IkappaB-alpha protein related to the inhibition of the activity of the transcription factor NF-kappaB.
Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Sonois V; Benarous R; Girault JP
Biochemistry; 2007 Mar; 46(11):2958-72. PubMed ID: 17319651
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu).
Henklein P; Schubert U; Kunert O; Klabunde S; Wray V; Klöppel KD; Kiess M; Portsmann T; Schomburg D
Pept Res; 1993; 6(2):79-87. PubMed ID: 8387359
[TBL] [Abstract][Full Text] [Related]
10. Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.
Estrabaud E; Le Rouzic E; Lopez-Vergès S; Morel M; Belaïdouni N; Benarous R; Transy C; Berlioz-Torrent C; Margottin-Goguet F
PLoS Pathog; 2007 Jul; 3(7):e104. PubMed ID: 17676996
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation-dependent structure of ATF4 peptides derived from a human ATF4 protein, a member of the family of transcription factors.
Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Benarous R; Girault JP
Peptides; 2007 Dec; 28(12):2253-67. PubMed ID: 17996332
[TBL] [Abstract][Full Text] [Related]
12. Structural consequences of phosphorylation of two serine residues in the cytoplasmic domain of HIV-1 VpU.
Wittlich M; Koenig BW; Willbold D
J Pept Sci; 2008 Jul; 14(7):804-10. PubMed ID: 18186541
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.
Friborg J; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):10-22. PubMed ID: 8548340
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
Grinstead JS; Schuman JT; Campbell AP
Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
[TBL] [Abstract][Full Text] [Related]
15. Solution structure and orientation of the transmembrane anchor domain of the HIV-1-encoded virus protein U by high-resolution and solid-state NMR spectroscopy.
Wray V; Kinder R; Federau T; Henklein P; Bechinger B; Schubert U
Biochemistry; 1999 Apr; 38(16):5272-82. PubMed ID: 10213635
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of a peptide derived from the oncogenic protein beta-Catenin in its phosphorylated and nonphosphorylated states.
Megy S; Bertho G; Gharbi-Benarous J; Baleux F; Benarous R; Girault JP
Peptides; 2005 Feb; 26(2):227-41. PubMed ID: 15629534
[TBL] [Abstract][Full Text] [Related]
17. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity.
Yao XJ; Friborg J; Checroune F; Gratton S; Boisvert F; Sékaly RP; Cohen EA
Virology; 1995 Jun; 209(2):615-23. PubMed ID: 7778293
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation.
Margottin F; Benichou S; Durand H; Richard V; Liu LX; Gomas E; Benarous R
Virology; 1996 Sep; 223(2):381-6. PubMed ID: 8806575
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of sialyl Lewis(x) bound to E-selectin using saturation transfer difference NMR experiments.
Rinnbauer M; Ernst B; Wagner B; Magnani J; Benie AJ; Peters T
Glycobiology; 2003 Jun; 13(6):435-43. PubMed ID: 12626392
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
